Infectious Disease Research Institute (IDRI) 3.7

IDRI is currently focused on eradicating tuberculosis, leishmaniasis, leprosy, malaria, and Chagas disease. As the global health arena evolves, our commitment to improving human health and our pragmatic focus on products will enable us to continue translating science into global health solutions. Our portfolio of programs comprises diseases that kill more than six million adults and children each year. These diseases have different etiologies, symptoms, global footprints, and challenges. Nevertheless, we have a singular goal for each: to develop products that save lives. We are proud of the significant progress we've made in achieving that goal.